SCHEMBL14545548

SCHEMBL14545548

CC(C)(C)OC(=O)N1CC(Oc2cnc(-c3ccc(F)cc3)c(-c3ccc(F)cc3)n2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CKS1B P61024 3/20 0.47
SKP1 P63208 3/20 0.47
SKP2 Q13309 3/20 0.47
TGFBR1 P36897 1/20 0.45
CACNB4 O00305 1/20 0.44
CACNA1A O00555 1/20 0.44
CACNA1G O43497 1/20 0.44
CACNG3 O60359 1/20 0.44
CACNA1F O60840 1/20 0.44
CACNA1H O95180 1/20 0.44
CACNB3 P54284 1/20 0.44
CACNA2D1 P54289 1/20 0.44
CACNG7 P62955 1/20 0.44
CACNA1B Q00975 1/20 0.44
CACNA1D Q01668 1/20 0.44
CACNB1 Q02641 1/20 0.44
CACNG1 Q06432 1/20 0.44
CACNB2 Q08289 1/20 0.44
CACNA1S Q13698 1/20 0.44
CACNA1C Q13936 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14544927 0.92 PIK3CD (0.49) CKS1BSKP1SKP2PIK3CDGPR119
SCHEMBL14545549 0.90 GPR119 (0.52) CKS1BSKP1SKP2CACNB4CACNA1A
SCHEMBL4694942 0.89 CACNB4 (0.53) CKS1BSKP1SKP2CACNB4CACNA1A
SCHEMBL14861989 0.81 GPR119 (0.51) CACNB4CACNA1ACACNA1GCACNG3CACNA1F
SCHEMBL14523450 0.78 CNR1 (0.52) CKS1BSKP1SKP2CACNB4CACNA1A
SCHEMBL14545551 0.77 CKS1B (0.53) CKS1BSKP1SKP2GRIA1GPR119
SCHEMBL16434828 0.76 USP30 (0.52) HDAC1HDAC2GPR119
SCHEMBL27111249 0.74 CACNB4 (0.45) CACNB4CACNA1ACACNA1GCACNG3CACNA1F
SCHEMBL6791900 0.73 GPR119 (0.61) CACNB4CACNA1ACACNA1GCACNG3CACNA1F
SCHEMBL4691844 0.73 CNR1 (0.43) CKS1BSKP1SKP2CACNB4CACNA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070078135-A1 Substituted heteroaryl CB1 antagonists NEUROGEN CORPORATION (US) 2007-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078135-A1 Substituted heteroaryl CB1 antagonists CNR1, CNR2, OPRL1 CKS1B 1836/4885SKP1 3576/4885SKP2 4014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.